Trademark: 88219962
Word
FIBRISTAL
Status
Dead
Status Code
606
Status Date
Monday, January 10, 2022
Serial Number
88219962
Mark Type
4000
Filing Date
Thursday, December 6, 2018
Published for Opposition
Tuesday, April 9, 2019
Abandoned Date
Monday, January 10, 2022

Trademark Owner History
Allergan Sales, LLC - Owner At Publication

Classifications
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment andprevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and preventionof iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for theprevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceuticalpreparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines forthe treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment ofdiabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the preventionand treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, central nervous system (CNS) disorders, neurological disorders, neurodegenerative disorders, and depression, pharmaceutical preparations, namely, neuroprotective agents; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facialaesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile antibiotic and anti-inflammatory ointments; ocular wetting solutions, namely, eye drops, artificialtears and pharmaceutical gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations,namely, medicated dry skin lotions and medicated creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, medicated toners, medicated moisturizers, medicated rejuvenators, medicated rehydrating creams, and medicated lotions for the face and body

Trademark Events
Jan 10, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 10, 2022
Abandonment - No Use Statement Filed
May 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 29, 2021
Extension 4 Granted
Apr 29, 2021
Extension 4 Filed
Apr 29, 2021
Teas Extension Received
Dec 4, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 2, 2020
Extension 3 Granted
Dec 2, 2020
Extension 3 Filed
Dec 2, 2020
Teas Extension Received
May 1, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 29, 2020
Extension 2 Granted
Apr 29, 2020
Extension 2 Filed
Apr 29, 2020
Teas Extension Received
Nov 23, 2019
Notice Of Approval Of Extension Request E-Mailed
Nov 21, 2019
Extension 1 Granted
Nov 21, 2019
Extension 1 Filed
Nov 21, 2019
Teas Extension Received
Jun 4, 2019
Noa E-Mailed - Sou Required From Applicant
Apr 9, 2019
Official Gazette Publication Confirmation E-Mailed
Apr 9, 2019
Published For Opposition
Mar 20, 2019
Notification Of Notice Of Publication E-Mailed
Feb 26, 2019
Approved For Pub - Principal Register
Feb 20, 2019
Assigned To Examiner
Dec 28, 2018
New Application Office Supplied Data Entered In Tram
Dec 10, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24